Wikisage, the free encyclopedia of the second generation, is digital heritage

Cyclophosphamide: Difference between revisions

From Wikisage
Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
as immunesupressor is used in nephrotic syndrome, [[Churg-Strauss_syndrome| granulomatosis]] and following organ transplant. <ref>[https://www.tandfonline.com/doi/abs/10.1080/17474086.2017.1318054?journalCode=ierr20 Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?]</ref><ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/ Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients]</ref>
as immunesupressor is used in nephrotic syndrome, [[Churg-Strauss_syndrome| granulomatosis]] and following organ transplant. <ref>[https://www.tandfonline.com/doi/abs/10.1080/17474086.2017.1318054?journalCode=ierr20 Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?]</ref><ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/ Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients]</ref>
<ref>[http://www.haematologica.org/content/104/10/e478.long T-Cell Replete Haploidentical Bone Marrow Transplantation And Post-Transplant Cyclophosphamide For Patients With Inborn Errors]</ref>
<ref>[http://www.haematologica.org/content/104/10/e478.long T-Cell Replete Haploidentical Bone Marrow Transplantation And Post-Transplant Cyclophosphamide For Patients With Inborn Errors]</ref><ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396776/ Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?]</ref>
<gallery>
<gallery>
File:Cc-R-cyclophosphamide-from-xtal-1996-3D-balls.png
File:Cc-R-cyclophosphamide-from-xtal-1996-3D-balls.png

Latest revision as of 00:19, 19 October 2019